NEOADJUVANT CHEMOIMMUNOTHERAPY
Clinical trials for NEOADJUVANT CHEMOIMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT CHEMOIMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT CHEMOIMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis phase 2 trial tests whether adding radiotherapy and two immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy can improve outcomes for people with resectable stomach or gastroesophageal junction cancer. About 40 participants will be randomly assigned to…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 26, 2026 16:10 UTC
-
Can a CT scan predict who will benefit from lung cancer chemoimmunotherapy?
Knowledge-focused Recruiting nowThis study looks at whether features on CT scans can predict how well non-small cell lung cancer responds to chemoimmunotherapy given before surgery. Researchers will compare CT images taken before and after treatment with the actual results from surgery. The goal is to develop a…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Robotic surgery under the microscope: can it handle tough lung cancer cases after chemoimmunotherapy?
Knowledge-focused Recruiting nowThis study is observing 100 people with stage IIB-III non-small cell lung cancer who have already received chemotherapy and immunotherapy. After that treatment, they will have robotic-assisted sleeve lobectomy (a type of lung surgery). The goal is to see how often the surgery is …
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Sponsor: Shanghai Chest Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can shrinking tumors before surgery improve robotic lung cancer outcomes?
Knowledge-focused Recruiting nowThis observational study enrolls 200 people with stage IIB-III non-small cell lung cancer who receive chemo-immunotherapy before robotic surgery. Researchers want to see if tumor and lymph node shrinkage (downstaging) leads to better surgical results, like complete tumor removal …
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Sponsor: Shanghai Chest Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Tattoo marks could help surgeons save more breasts in cancer fight
Knowledge-focused Recruiting nowThis study tests whether tattooing the skin over a breast tumor before chemotherapy can help surgeons later remove the cancer completely while saving as much healthy breast tissue as possible. Thirty women with breast cancer will get their tumor edges marked with tattoo ink, then…
Matched conditions: NEOADJUVANT CHEMOIMMUNOTHERAPY
Phase: NA • Sponsor: All India Institute of Medical Sciences, Bhubaneswar • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC